NatashaRekhtmanMD

Pathology • New York, NY

Cytopathology, Pulmonary Pathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Rekhtman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rekhtman's full profile

Already have an account?

Office
1275 York Avenue
New York, NY 10065

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Cytopathology, 2007 - 2008
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2002 - 2006
Albert Einstein College of MedicineClass of 2002

Certifications & Licensure

NJ State Medical License 2024 - 2025
NY State Medical License 2007 - 2025
MD State Medical License 2006 - 2007
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Cytopathology

Publications & Presentations

PubMed

First Report of Response to Tarlatamab in a Patient With DLL3-Positive Pulmonary Carcinoid: Case Report.
Alissa J Cooper, Natasha Rekhtman, Marina K Baine, Marie C Thomas, Alia C Lynch
JTO Clinical and Research Reports. 2024-12-01
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-like Carcinoma.
Christopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, Umesh Bhanot, Peter Ntiamoah
Modern Pathology. 2024-11-27
Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From t...
Teh-Ying Chou, Sanja Dacic, Ignacio Wistuba, Mary Beth Beasley, Sabina Berezowska
Journal of Thoracic Oncology. 2024-11-22

Journal Articles

PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers
G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
Pathologic Features of Response to Neoadjuvant Anti-PD-1 in Resected Non-Small Cell Lung Carcinoma: A Proposal for Quantitative Immune-Related Pathologic Response Crit...
J M Isbell, N Rekhtman, J D Wolchok, J E Chaft, Annals of Oncology

Press Mentions

MSK Researchers Discover New Type of SCLCSeptember 18th, 2024
Memorial Sloan Kettering Identifies New Lung CancerSeptember 12th, 2024
New, Rare Type of Small Cell Lung Cancer IdentifiedSeptember 11th, 2024
Join now to see all